1. Home
  2. Live Updates
  3. Dupilumab

Dupilumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dupilumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dupilumab Today - Breaking & Trending Today

FDA Accepts sBLA for Priority Review of Dupilumab for Uncontrolled COPD

The FDA’s decision is planned for June 2024, and follows the successful results of the BOREAS and NOTUS trials. ....

Drug Administration , Biologics License Application , Priority Review ,

Abrocitinib Effective for Eczema Patients with Inadequate Response to Upadacitinib, Dupilumab

This research also included results from a sub-analysis of non-responders with hand eczema to dupilumab and upadacitinib. ....

University Medical Center Groningen , Dutch Bioday , Investigator Global Assessment , Eczema Area , Severity Index , Hand Eczema Severity Index , Atopic Dermatitis , Hand Eczema ,

Study: Tralokinumab Shows More Frequent Injection Site Reactions Than Dupilumab in Patients With AD

Although injection site reactions were common occurrences in both the tralokinumab and dupilumab groups, tralokinumab caused ISRs more frequently. ....

Image Credit , Dermatology Unit , Naples Federico , Numerical Rating Scale , Atopic Dermatitis , Injection Site Reactions ,

Combination Dupilumab, Topical Corticosteroids Treatment Demonstrated Efficacy in Children With AD

Dupilumab and topical corticosteroids can be used to treat symptoms in children with atopic dermatitis (AD). ....

Image Credit , Eczema Area , Severity Index , Dermatology Life Quality Index , Global Assessment , Cochrane Handbook , Systemic Reviews , Interventions Risk , Bias Tool , Atopic Dermatitis , Topical Corticosteroids , Children With Ad ,

Gastroenterology Month in Review: January 2024

Our January 2024 Month in Review spotlights the FDA approval of a new indication of dupilumab (Dupixent) for pediatric eosinophilic esophagitis, new clinical trial data, and research about the prevention and management of IBD. ....

Evan Dellon , Dupilumab Dupixent , Julie Khlevner , Drug Administration , University Of North Carolina Chapel Hill , Contemporary Pediatric , Esophageal Diseases , North Carolina Chapel Hill , Pediatric Gastrointestinal Motility Center , Columbia University Medical Center , Inflammatory Bowel Disease , Eosinophilic Esophagitis , Ulcerative Colitis ,